Read more about the latest developments in MS research, treatments and specialist care, plus the latest updates on our work and the efforts of our amazing supporters
The MS Trust sends out a weekly news alert which includes the latest updates from the MS Trust, latest news, blogs and a news feed from MS in the Media.
Read our latest news
As the final data from the MS Risk-Sharing scheme (RSS) is published in the BMJ, we reflect on how this pioneering scheme has changed the landscape for people living with MS.
The MS Trust has praised the pioneering work of the MS Risk Sharing Scheme (RSS) as the final results from the scheme are published in the BMJ today (September 24).
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 11, where Hellie wonders if she will still remain on the trial.
On 9 September, our team of 34 runners took on the iconic 13.1-mile route from Newcastle to South Shields.
Guest blogger Emily, also known as the wibbly dinosaur, writes about her life after being diagnosed with MS, and why she started blogging to help others who are new to MS.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 10, where Hellie starts taking the drug again, but then has to stop again.
- Ocrevus turned down for PPMS
- Ocrevus slows progression
- Prevalence of benign MS
- Statins trial starts in SPMS
- Gilenya effective in childhood MS
The MS Trust is delighted to announce that it will feature in the September BBC Lifeline Appeal at 2.45pm this Sunday (September 16) on BBC One. Please tune in and help us raise awareness of MS and the work of the MS Trust.
In light of today's news on ocrelizumab for primary progressive MS (PPMS), Ian Daly writes about the day to day reality of living with PPMS.
The MS Trust is hugely disappointed that NICE is unable to recommend ocrelizumab as an NHS treatment for early primary progressive MS.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 9, where Hellie gets to see her "impressive" yet alarming liver values.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 8, where Hellie suddenly encounters a bunch of issues.
Being, a short film directed by Devlin Crow, tells the story of a young boy who cares for his mother who has MS.
- Ibudilast slows atrophy in progressive MS
- Sleep affects MS symptoms
- Tecfidera and Gilenya compared
- Managing functional illness
Ibudilast slowed down the loss of brain volume in primary and secondary progressive MS by almost one half compared to placebo according to results published in the New England Journal Of Medicine.
Rich from Dorset tells us why he is taking on a 50-mile tandem cycle challenge in aid of the MS Trust.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 7, where Hellie gets chatting to someone who is finishing the trial